Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis()

OBJECTIVES: The COVID-19 pandemic has consumed considerable resources and has impacted the delivery of cancer care. Patients with cancer may have factors which place them at high risk for COVID 19 morbidity or mortality. Highly immunosuppressive chemotherapy regimens and possible exposure to COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Pothuri, Bhavana, Alvarez Secord, Angeles, Armstrong, Deborah K., Chan, John, Fader, Amanda N., Huh, Warner, Kesterson, Joshua, Liu, Joyce F., Moore, Kathleen, Westin, Shannon N., Naumann, R. Wendel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177100/
https://www.ncbi.nlm.nih.gov/pubmed/32386911
http://dx.doi.org/10.1016/j.ygyno.2020.04.694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177100/
https://www.ncbi.nlm.nih.gov/pubmed/32386911
http://dx.doi.org/10.1016/j.ygyno.2020.04.694

Ejemplares similares